Lipco Pharmaceuticals Private Limited

Lipco Pharmaceuticals Private Limited - chemicals in Goregaon East, Maharashtra, India. FY 2026 financials and compliance.
CIN U24290MH2020PTC436205 Incorporated 31 August 2020 ROC Mumbai HQ Goregaon East, Maharashtra, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2024
₹98.66 Lakh
▲ 17.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Lipco Pharmaceuticals Private Limited

Data last updated: 07 February 2026

Lipco Pharmaceuticals Private Limited is a private limited company based in Goregaon East, Maharashtra, India. It specialises in manufacturing, a part of the broader chemicals sector. Incorporated on 31 August 2020, the company has been in operation for over 6 years.

Registered with ROC Mumbai under CIN U24290AS2020PTC020401.

Capital: an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Dikshita Sarkar and Ankita Sarkar.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Goregaon East, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹98.66 Lakh, a growth of 17% compared to the previous year.

Company Details of Lipco Pharmaceuticals Private Limited
CIN U24290MH2020PTC436205
Registration Number 436205
Incorporation Date 31 August 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    605 Ananta Tower C – Wing Gen. Arun Kumar Vaidya, Goregaon (East) Near Film City Shree Krishna Nagar, Goregaon East, Maharashtra, India – 400065
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Company report
Lipco Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Lipco Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Lipco Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Lipco Pharmaceuticals Private Limited

Lipco Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24290AS2020PTC020401. The current CIN is U24290MH2020PTC436205, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24290MH2020PTC436205 Current
U24290AS2020PTC020401 Previous

Business Activity of Lipco Pharmaceuticals Private Limited

Lipco Pharmaceuticals Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Lipco Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Lipco Pharmaceuticals Private Limited

Lipco Pharmaceuticals Private Limited is governed by 4 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Dikshita Sarkar Additional Director 23 Oct 2024 1 Years 9 Months Current
Ankita Sarkar Director 31 Aug 2020 5 Years 11 Months Current
Subrata Sarkar Director 31 Aug 2020 5 Years 11 Months Current
Shefali Sarkar Director 31 Aug 2020 5 Years 11 Months Current

Financials of Lipco Pharmaceuticals Private Limited FY 2025 filings available

Lipco Pharmaceuticals Private Limited reported revenue of ₹98.66 Lakh (up 17.00% YoY) for FY 2024.

Revenue · FY 2024
₹98.66 Lakh ▲ 17.00%
Premium access

Ten-year financial statements for Lipco Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Lipco Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Lipco Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Lipco Pharmaceuticals Private Limited

Lipco Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Lipco Pharmaceuticals Private Limited

Lipco Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 08, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Lipco Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Lipco Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Lipco Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Lipco Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Lipco Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Lipco Pharmaceuticals Private Limited

Premium access

MSME payment history for Lipco Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Lipco Pharmaceuticals Private Limited

Premium access

Corporate group structure for Lipco Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Lipco Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Lipco Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Lipco Pharmaceuticals Private Limited

Activity
30 Sep 2025
Lipco Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Lipco Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
23 Oct 2024
Dikshita Sarkar was appointed as a Additional Director on 23 Oct 2024 & has been associated with this company since 1 year 9 months.
Directors
31 Aug 2020
Ankita Sarkar was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 11 months.
Directors
31 Aug 2020
Subrata Sarkar was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 11 months.
Directors
31 Aug 2020
Shefali Sarkar was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 11 months.

Frequently Asked Questions about Lipco Pharmaceuticals Private Limited

Lipco Pharmaceuticals Private Limited is an active private limited company in the chemicals sector based in Goregaon East, Maharashtra, India. It was incorporated on 31 August 2020 (6+ years old) and is registered under CIN U24290MH2020PTC436205.

Lipco Pharmaceuticals Private Limited reported revenue of ₹98.66 Lakh for FY 2024 (up 17.00% YoY).

The current directors of Lipco Pharmaceuticals Private Limited are:

The primary industry of Lipco Pharmaceuticals Private Limited is chemicals. The company specifically operates in manufacturing. The company is currently active in this sector.

Lipco Pharmaceuticals Private Limited can be reached at the registered office: 605 Ananta Tower C – Wing Gen. Arun Kumar Vaidya, Goregaon East Near Film City Shree Krishna Nagar, Goregaon East, Maharashtra, India – 400065.

The authorised capital is ₹15 Lakh, and the paid-up capital is ₹15 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available